Macdonald JS, Astrow AB. Adjuvant therapy of colon cancer. Semin Oncol. 2001;28:30–40.

Article  CAS  PubMed  Google Scholar 

Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004;22:1797–806.

Article  CAS  PubMed  Google Scholar 

André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.

Article  PubMed  Google Scholar 

Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.

Article  PubMed  Google Scholar 

West NP, Kobayashi H, Takahashi K, et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012;30:1763–9.

Article  PubMed  Google Scholar 

Kobayashi H, West NP, Takahashi K, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21(Suppl 3):S398-404.

Article  PubMed  Google Scholar 

Kotake K, Mizuguchi T, Moritani K, et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis. 2014;29:847–52.

Article  PubMed  Google Scholar 

Numata M, Sawazaki S, Aoyama T, et al. D3 lymph node dissection reduces recurrence after primary resection for elderly patients with colon cancer. Int J Colorectal Dis. 2019;34:621–8.

Article  PubMed  Google Scholar 

Påhlman LA, Hohenberger WM, Matzel K, et al. Should the benefit of adjuvant chemotherapy in colon cancer be re-evaluated? J Clin Oncol. 2016;34:1297–9.

Article  PubMed  Google Scholar 

Macdonald JS. Adjuvant therapy of colon cancer. CA Cancer J Clin. 1999;49:202–19.

Article  CAS  PubMed  Google Scholar 

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995; 345:939–44

Haller DG, Tabernero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–71.

Article  CAS  PubMed  Google Scholar 

Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis. 2009;11:354–64 ((discussion 364-5)).

Article  CAS  PubMed  Google Scholar 

Gundestrup AK, Olsen ASF, Ingeholm P, et al. Nonmicroradical resection margin as a predictor of recurrence in patients with stage III colon cancer undergoing complete mesocolic excision: a prospective cohort study. Dis Colon Rectum. 2022;65:683–91.

Article  PubMed  Google Scholar 

Bertelsen CA, Neuenschwander AU, Jansen JE, et al. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study. Lancet Oncol. 2019;20:1556–65.

Article  PubMed  Google Scholar 

Shimada Y, Hamaguchi T, Mizusawa J, et al. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205. Eur J Cancer. 2014;50:2231–40.

Article  CAS  PubMed  Google Scholar 

Bae SU, Saklani AP, Lim DR, et al. Laparoscopic-assisted versus open complete mesocolic excision and central vascular ligation for right-sided colon cancer. Ann Surg Oncol. 2014;21:2288–94.

Article  PubMed  Google Scholar 

Kitano S, Inomata M, Mizusawa J, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2017;2:261–8.

Article  PubMed  Google Scholar 

Fujii S, Akagi T, Inomata M, et al. Transitional impact of short- and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404. Ann Gastroenterol Surg. 2019;3:301–9.

Article  PubMed  PubMed Central  Google Scholar 

Park JS, Kang H, Park SY, et al. Long-term oncologic after robotic versus laparoscopic right colectomy: a prospective randomized study. Surg Endosc. 2019;33:2975–81.

Article  PubMed  Google Scholar 

Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med. 2018;378:1177–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe J, Sasaki S, Kusumoto T, et al. S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial. ESMO Open. 2021;6:100077.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bennouna J, André T, Campion L, et al. Rationale and design of the IROCAS study: multicenter, international, randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in patients with high-risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial. Clin Colorectal Cancer. 2019;18:e69–73.

Article  PubMed  Google Scholar 

Lee KH, Yang IJ, Ha GW, et al. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial. BMC Cancer. 2024;24:397.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaanan A, Shi Q, Taieb J, et al. Role of Deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy: a pooled analysis from 2 randomized clinical trials. JAMA Oncol. 2018;4:379–83.

Article  PubMed  Google Scholar 

André T, de Gramont A, Vernerey D, et al. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC Study. J Clin Oncol. 2015;33:4176–87.

Article  PubMed  Google Scholar 

Argilés G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1291–305.

Article  PubMed  Google Scholar 

Keikes L, van Oijen MGH, Lemmens V, et al. Evaluation of Guideline adherence in colorectal cancer treatment in The Netherlands: a survey among medical oncologists by the dutch colorectal cancer group. Clin Colorectal Cancer. 2018;17:58–64.

Article  PubMed  Google Scholar 

Reinert T, Henriksen TV, Christensen E, et al. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer. JAMA Oncol. 2019;5:1124–31.

Article  PubMed  PubMed Central  Google Scholar 

Kasi PM, Fehringer G, Taniguchi H, et al. Impact of circulating tumor DNA-based detection of molecular residual disease on the conduct and design of clinical trials for solid tumors. JCO Precis Oncol. 2022;6:e2100181.

Article  PubMed  PubMed Central  Google Scholar 

Kotani D, Oki E, Nakamura Y, et al. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer. Nat Med. 2023;29:127–34.

Article  CAS  PubMed  PubMed Central  Google Scholar